Tag Archives: Lung

InterMune Denied Approval for Lung Treatment

Image via Wikipedia Biotech firm InterMune took an ugly hit on Tuesday as news broke that its lung disease drug Esbriet (pirfenidone) will require additional clinical studies, and won’t be getting the seal of approval from FDA any time soon. The news caused InterMune’s stock to drop a staggering 78 percent, according to Reuters. Analysts […]
Posted in FDA, Strategy | Also tagged , , , , , | 1 Comment
  • Categories

  • Meta